Critically ill tube fed neonates and children Not Applicable
Conditions
Interventions
This feasibility study will examine clinician and parent views around a trial of not undertaking this routine intervention of GRV measurement and once trial inclusion/exclusion criteria are agreed the
Sponsors
University Hospitals Bristol
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthcare professionals working in UK PICU and NICUs who are involved in decision-making around feeding (nurses, doctors and dieticians) 2. Parents of children who have been in a UK PICU or NICU
Exclusion criteria
Exclusion criteria: Non PICU or NICU staff or parents who have not had this experience
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Possibility of conducting a trial of not measuring gastric residual volume (GRV) in UK pediatric and neonatal intensive care units | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Standard care practices around enteral feeding and GRV measurement assessed using an e-survey in all UK PICUs and NICUs 2. Healthcare professionals (nurses, doctors and dietitians) views around GRV measurement, acceptability of not measuring GRV, alternative methods to assess feed tolerance, willingness to randomise to or comply with a future trial, barriers to recruitment, perceived training needs and inclusion and exclusion criteria 3. PICU and NICU parents' and/or patients' views around GRV measurement, acceptability of not measuring GRV, willingness to agree to a future trial, barriers to recruitment, patient (parent) centred outcomes and information needs for parents 4. Consensus on future trial issues including optimal trial design, primary and secondary outcome measures and inclusion and exclusion criteria 5. Trial feasibility (in both PICU and NICU) assessed using routinely collected national clinical datasets (PICANet and NNRD) and sample size calculations for a future trial 6. A standard (control) arm (with routine GRV measurement) and an intervention arm (no routine GRV measurement) of a future trial, agreed using a consensus process The questionnaires are currently being developed as no existing tools are suitable. There will be one baseline measurement (at 1 month) of existing practice, then a further questionnaire around optimal research design at month 4. | — |
Countries
United Kingdom
Outcome results
None listed